Selvita stock trades at PLN 80.00 as research growth continues

Published on 09/23/2026 at 02:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Selvita stock traded at PLN 80.00 on September 22, 2026, while its 52-week range stood at PLN 57.00 to PLN 96.00. The company reported 2025 revenue of PLN 540 million.

Selvita, PLSEV0000014, Illustration mit AI erstellt.

Selvita stock traded at PLN 80.00 on the Warsaw Stock Exchange on September 22, 2026. The reference quote stood within the 52-week range of PLN 57.00 to PLN 96.00, giving investors a dated market level alongside the company's research-services profile.

Research activity supports the valuation

Selvita reported revenue of PLN 540 million for fiscal year 2025. That figure provides the latest visible annual operating reference for the drug-discovery and development services group.

The comparison with the 52-week range is material: the September 22 price was PLN 16.00 below the yearly high and PLN 23.00 above the yearly low. The stock therefore traded 16.67 percent below the high and 40.35 percent above the low, based on the same dated market snapshot.

Operating scale remains the key figure

Selvita's fiscal-year 2025 revenue of PLN 540 million is the central scale indicator for the business. Its model combines research services with work for pharmaceutical and biotechnology customers, making revenue development and project execution important measures for the equity story.

For investors, the numerical spread between the 52-week low and high is the clearest current risk marker available from the market data: PLN 39.00 separates the two reference points. The September 22 quote was 40.35 percent above the low but still 16.67 percent below the high.

Selvita stock remains below its high

Selvita stock closed at PLN 80.00 on the Warsaw Stock Exchange on September 22, 2026, against a 52-week low of PLN 57.00 and high of PLN 96.00. Fiscal-year 2025 revenue was PLN 540 million.